Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FWSQY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,143
Award facts
- Contract value 100% obligated
- $7,142.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,142.86 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count unit dosage) on August 19, 2025, with completion scheduled for August 20, 2025. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
As the prime contractor on the SPE2DX vehicle, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support federal military and healthcare systems worldwide. The global pharmaceutical support contract enables the company to fulfill medical procurement requirements across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. This particular delivery order for RINVOQ ER—a prescribed treatment for rheumatoid arthritis and other autoimmune conditions—exemplifies the routine pharmaceutical supply deliveries executed under the larger prime vendor contract structure, which DLA Troop Support intends to evolve through its planned Pharmaceutical Prime Vendor Global Program Generation V contracts.
Quick answers
Who was awarded contract SPE2DB25FWSQY?
SPE2DB25FWSQY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FWSQY worth?
The government has obligated $7,143 on SPE2DB25FWSQY.
Is contract SPE2DB25FWSQY an order under another contract?
Yes. SPE2DB25FWSQY is a delivery order under SPE2DB25D3007, an indefinite delivery contract.
Was contract SPE2DB25FWSQY competed?
The extent of competition for SPE2DB25FWSQY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award